MedPath

Trial to compare post-operative analgesia of ropivacaine versus dexmedetomidine and ropivacaine in pectoral nerve block for breast cancer surgery.

Not Applicable
Conditions
Health Condition 1: - Health Condition 2: C509- Malignant neoplasm of breast of unspecified siteHealth Condition 3: C509- Malignant neoplasm of breast of unspecified site
Registration Number
CTRI/2019/08/020815
Lead Sponsor
SMS MEDICAL COLLEGE JAIPUR
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

PATIENT UNDERGOING BREAST SURGERY.

ASA GRADE 1 AND 2.

Exclusion Criteria

PATIENT REFUSAL.

DERANGED COAGULATION PROFILE.

INFECTION AT INJECTION SITE.

HISTORY OF OPIOID USE OR ADDICTION.

OBESITY WITH BMI >35 KG/METER SQUARE.

PREGNANCY.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
FIRST RESCUE ANALGESIA.Timepoint: 24HOURS
Secondary Outcome Measures
NameTimeMethod
TOTAL POST OPERATIVE ANALGESIC CONSUMPTION. <br/ ><br>SIDE EFFECTS IF ANY.Timepoint: 24HOURS
© Copyright 2025. All Rights Reserved by MedPath